Levothyroxine Sodium Injection, Powder, Lyophilized, For Solution
FDA Label NDC 70771-1818

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Levothyroxine Sodium (NDC 70771-1818). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1818-1

Levothyroxine Sodium for Injection

100 mcg per vial

For Intravenous Use

Discard any unused portion

Single-Dose Vial

Rx only

100 Mcg Carton Label (58d487b9 D60d 4b2b B9ca 5ee151707c15 01)

NDC 70771-1819-1

Levothyroxine Sodium for Injection

200 mcg per vial

For Intravenous Use

Discard any unused portion

Single-Dose Vial

Rx only

200 Mcg Carton Label (58d487b9 D60d 4b2b B9ca 5ee151707c15 02)

NDC 70771-1820-1

Levothyroxine Sodium for Injection

500 mcg per vial

For Intravenous Use

Discard any unused portion

Single-Dose Vial

Rx only

500 Mcg Label (58d487b9 D60d 4b2b B9ca 5ee151707c15 03)

* Please review the disclaimer below.